Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
America Great HealthAAGH -20.00% EV-to-EBIT is 7.21 as of Sep. 09, 2026. The stock has 4 warning signs investors should review. Among 365 Biotechnology companies, America Great Health ranks better than 64.66% on this metric.
America Great Health (OTCPK:AAGH) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
America Great Health's Enterprise Value for the quarter that ended in Mar. 2026 was $5.13 Mil.
America Great Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.01 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
America Great Health EV-to-EBIT Related Terms
America Great Health EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for America Great Health's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, America Great Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
America Great Health EV-to-EBIT vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, America Great Health's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where America Great Health's EV-to-EBIT falls into.
America Great Health's current Enterprise Value is $7.24 Mil.
America Great Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.01 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
America Great Health (AAGH) has a EV-to-EBIT of 7.21 as of Sep. 09, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on America Great Health and its competitors. According to the industry distribution chart, America Great Health ranks #129 out of 365 companies in the Biotechnology industry, placing it in the top 35.3%.
Is America Great Health's EV-to-EBIT too high?
America Great Health's current EV-to-EBIT is 7.21. The Biotechnology industry median EV-to-EBIT is 15.48. America Great Health's value of 7.21 is 53.4% below this industry median. Based on the distribution chart, America Great Health ranks #129 out of 365 companies in the Biotechnology industry, which is above the industry midpoint.
How does America Great Health's EV-to-EBIT compare to HCWB and CLGN?
According to the Biotechnology industry distribution chart, America Great Health ranks #129 out of 365 companies for EV-to-EBIT. This puts America Great Health in the upper half of its industry. The industry median EV-to-EBIT is 15.48. America Great Health's value of 7.21 is 53.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Biotechnology company?
The median EV-to-EBIT among Biotechnology companies is 15.48, based on 365 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. America Great Health's current EV-to-EBIT of 7.21 is 53.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on America Great Health and its competitors. For the Biotechnology industry, the median EV-to-EBIT is 15.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. America Great Health's current EV-to-EBIT is 7.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is America Great Health stock overvalued right now?
America Great Health (AAGH) has a current EV-to-EBIT of 7.21. The current EV-to-EBIT is 7.21 and 53.4% below the Biotechnology industry median of 15.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For America Great Health (AAGH), the current EV-to-EBIT is 7.21 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
America Great Health operates as a biotechnology company. The company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AAGH has been successfully added to your 
